Taking a GLP-1 receptor agonist was associated with a lower risk for cirrhosis and related complications in patients with ...

Research on the gut microbiome has triggered a 'revolution' in nutritional science, and in the last few years, dietary fiber ...

Wegovy and similar weight-loss medications are becoming widely prescribed for teenagers with obesity, but little is known ...

The health secretary said the injections are not 'cosmetic' treatments and should only be used by obese people who have ...

Renowned plant-based physician Dr. Michael Greger has released a new book on the risks, benefits, and alternatives to Ozempic ...

Multiple sessions and virtual care companies touted the potential of glucagon-like peptide-1 agonist drugs to help patients ...

Some influencers are calling protein "nature's Ozempic." But can protein naturally stimulate your GLP-1 levels just like a ...

The Medicaid budget survey for fiscal years 2024 and 2025 revealed state predictions are expecting a decline in Medicaid ...

Less than a week after the U.S. Food & Drug Administration (FDA) determined that the shortage of the tirzepatide injection, a glucagon-like peptide ...

The UK medicines regulator has asked doctors to look out for “signs of misuse” of weight loss drugs among their patients. It ...